# Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device

> **NCT02449304** · PHASE4 · UNKNOWN · sponsor: **Birmingham Women's NHS Foundation Trust** · enrollment: 50 (actual)

## Conditions studied

- Heavy Menstrual Bleeding

## Interventions

- **DEVICE:** Endometrial ablation (4th gen)

## Key facts

- **NCT ID:** NCT02449304
- **Lead sponsor:** Birmingham Women's NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2015-10
- **Final completion:** 2020-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449304, "Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02449304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*